Home

Suven Life Sciences Ltd PE Ratio

Image

Suven Life Sciences Ltd

NSE: SUVEN

PE

-

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Suven Life Sciences Ltd is 0 as of 15 Jan 9.00 AM .
  • The P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Suven Life Sciences Ltd is ₹ 130.1 as of 14 Jan 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 34.6 to 62.9 in 5 years. This represents a CAGR of 12.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.9. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Suven Life Sciences Ltd

No data available

Company Fundamentals for Suven Life Sciences Ltd

Image

Suven Life Sciences Ltd

NSE: SUVEN

Share Price

₹ 130.1

-4.10 (-3.06%)

stock direction

Last updated on: Jan 14, 2025

Market Price of Suven Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Suven Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025130.1
13 Jan 2025134.2
10 Jan 2025128.55
09 Jan 2025134.2
08 Jan 2025140.5
07 Jan 2025126.65
06 Jan 2025122.9
03 Jan 2025128.7
02 Jan 2025128.7
01 Jan 2025128.25

SWOT Analysis Of Suven Life Sciences Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Suven Life Sciences Ltd

Asset Value vs Market Value of Suven Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Suven Life Sciences Ltd2837
Max Healthcare Institute Ltd105656
Apollo Hospitals Enterprise Ltd96403
Fortis Healthcare Ltd50103
Syngene International Ltd33340

PE Ratio of Suven Life Sciences Ltd Explained

``

2837

Market cap

-145

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Suven Life Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Suven Life Sciences Ltd

No data available

* All values are in %

About Suven Life Sciences Ltd

  • Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989.
  • The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
  • Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
  • Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

Suven Life Sciences Ltd News Hub

Indices trade with major losses; media shares under pressure

The headline equity benchmarks traded with deep cuts in the mid-afternoon trade. The decline was dri

Read more

2024-08-05 00:00:00

Suven Life Sciences reports consolidated net loss of Rs 28.04 crore in the June 2024 quarter

Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against

Read more

2024-08-05 00:00:00

Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr

Consolidated net sales slipped 73.42% year on year (YoY) to Rs 1.01 crore in the quarter ended 30 Ju

Read more

2024-08-05 00:00:00

Suven Life Sciences announces board meeting date

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 October 2024.

Read more

2024-10-21 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Suven Life Sciences Ltd

What is the current PE Ratio of Suven Life Sciences Ltd?

The Current PE Ratio of Suven Life Sciences Ltd is 0.0 as on 15 Jan 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 62.9 as on 15 Jan 2025.

What was the PE Ratio of Suven Life Sciences Ltd last year?

The PE Ratio of Suven Life Sciences Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Suven Life Sciences Ltd indicate about its stock?

The PE Ratio of Suven Life Sciences Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Suven Life Sciences Ltd.

What is the PE Ratio Growth of Suven Life Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Suven Life Sciences Ltd grew by -% whereas, the EPS ratio grew by 76.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions